Clinical Trial Update: A Study of Mirdametinib in People With Central Nervous System Tumors [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on an ongoing Phase 1/Phase 2 clinical trial evaluating Mirdametinib in people with central nervous system tumors, including gl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Tumors
• Glioma

Drugs mentioned

• Mirdametinib (mirdametinib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Central Nervous System Tumors, Glioma | Phase 1, Phase 2 | Status: RECRUITING